A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication

Weiss Norbert; Nikoi Sigrid; Rosen Yael; Patel Manesh R.

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication

【24h】

A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication

机译：II期，随机，双盲，多中心，跨国，安慰剂对照，并行组研究，以评估肌内肌肉内浸渍细胞肌内注射治疗受试者的安全性和疗效。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2018年第25期|共2页
作者
Weiss Norbert; Nikoi Sigrid; Rosen Yael; Patel Manesh R.;
展开▼
作者单位

Tech Univ Dresden Univ Ctr Vasc Med Univ Hosp Carl Gustav Carus Dresden Germany;

Asklepios Klin St Georg Dept Angiol Hamburg Germany;

Pluristem Therapeut Inc Med Affairs Haifa Israel;

Duke Univ Hlth Syst Div Cardiol Durham NC USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献

1. A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication [J] . Weiss Norbert, Nikoi Sigrid, Rosen Yael, Circulation: An Official Journal of the American Heart Association . 2018,第25期

机译：II期，随机，双盲，多中心，跨国，安慰剂对照，并行组研究，以评估肌内肌肉内浸渍细胞肌内注射治疗受试者的安全性和疗效。
2. Rationale and design of the MODIFY study: A phase 3 multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease [J] . Molecular genetics and metabolism . 2020,第2期

机译：修饰研究的理由和设计：第3阶段多中心，双盲，随机，安慰剂控制，并行群体研究，以确定Lucerastat口服单药治疗成人对象的疗效和安全性
3. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study [J] . Michihiro Hide, Akiko Yagami, Michinori Togawa, Allergology international: official journal of the Japanese Society of Allergology . 2017,第2期

机译：Bilastine在日本慢性自发性荨麻疹患者中的疗效和安全性：一项多中心，随机，双盲，安慰剂对照，平行组II / III期研究
4. A Phase 1B, Double-blind, Placebo-controlled, Parallel-group, Multi-dose Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis and Fecal Fat in Subjects with Functional Constipation [D] . Oduyebo, Ibironke. 2018

机译：1B，双盲，安慰剂控制，并行组，NGM282对结肠转运，胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
5. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter randomized double-blind placebo-controlled parallel-group phase II study [O] . T. Yokota, T. Ogawa, S. Takahashi, 2017

机译：瑞巴派特液体对头颈部癌患者放化疗治疗口腔黏膜炎的疗效和安全性：一项多中心随机双盲安慰剂对照平行组II期研究
6. Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction [O] . C. Michael Gibson, John J.P. Kastelein, Adam T. Phillips, 2021

机译：Apoa-i事件的理由和设计减少缺血综合征II（AEGIS-II）：3阶段，多中心，双盲，随机，安慰剂控制，并行组研究，以研究CSL112在受试者中的疗效和安全性急性心肌梗塞

A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication

著录项

相似文献

相关主题

期刊订阅